ETV5 links the FGFR3 and Hippo signalling pathways in bladder cancer
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
ETV5 links the FGFR3 and Hippo signalling pathways in bladder cancer
Authors
Keywords
-
Journal
Scientific Reports
Volume 9, Issue 1, Pages -
Publisher
Springer Nature
Online
2019-04-05
DOI
10.1038/s41598-018-36456-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- ETS (E26 transformation-specific) up-regulation of the transcriptional co-activator TAZ promotes cell migration and metastasis in prostate cancer
- (2017) Chen-Ying Liu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Negative feedback regulation of the ERK1/2 MAPK pathway
- (2016) David Lake et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Role of YAP/TAZ in cell-matrix adhesion-mediated signalling and mechanotransduction
- (2016) Sirio Dupont EXPERIMENTAL CELL RESEARCH
- A Hippo and Fibroblast Growth Factor Receptor Autocrine Pathway in Cholangiocarcinoma
- (2016) Sumera Rizvi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Oncogenic Gene Fusion FGFR3-TACC3 Is Regulated by Tyrosine Phosphorylation
- (2016) K. N. Nelson et al. MOLECULAR CANCER RESEARCH
- Identification of Pharmacodynamic Transcript Biomarkers in Response to FGFR Inhibition by AZD4547
- (2016) O. Delpuech et al. MOLECULAR CANCER THERAPEUTICS
- Verteporfin, a suppressor of YAP–TEAD complex, presents promising antitumor properties on ovarian cancer
- (2016) Zhengyu Li et al. OncoTargets and Therapy
- Nidogen 1 and Nuclear Protein 1: novel targets of ETV5 transcription factor involved in endometrial cancer invasion
- (2015) Núria Pedrola et al. CLINICAL & EXPERIMENTAL METASTASIS
- Control of tissue growth by Yap relies on cell density and F-actin in zebrafish fin regeneration
- (2015) R. Mateus et al. DEVELOPMENT
- Roles of Hippo signaling pathway in size control of organ regeneration
- (2015) Shinichi Hayashi et al. DEVELOPMENT GROWTH & DIFFERENTIATION
- Alteration of Cell–Cell and Cell–Matrix Adhesion in Urothelial Cells: An Oncogenic Mechanism for Mutant FGFR3
- (2014) Erica di Martino et al. MOLECULAR CANCER RESEARCH
- Overexpression of YAP 1 contributes to progressive features and poor prognosis of human urothelial carcinoma of the bladder
- (2013) Jian-Ye Liu et al. BMC CANCER
- An integrated genomic, transcriptional and protein investigation ofFGFRL1as a putative 4p16.3 deletion target in bladder cancer
- (2013) Erica di Martino et al. GENES CHROMOSOMES & CANCER
- The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment
- (2013) Randy Johnson et al. NATURE REVIEWS DRUG DISCOVERY
- ETV1, 4 and 5: An oncogenic subfamily of ETS transcription factors
- (2012) Sangphil Oh et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- FGFR3 Stimulates Stearoyl CoA Desaturase 1 Activity to Promote Bladder Tumor Growth
- (2012) X. Du et al. CANCER RESEARCH
- A Molecular Taxonomy for Urothelial Carcinoma
- (2012) G. Sjodahl et al. CLINICAL CANCER RESEARCH
- Oncogenic FGFR3 gene fusions in bladder cancer
- (2012) Sarah V. Williams et al. HUMAN MOLECULAR GENETICS
- ETV5 as a regulator of matrix metalloproteinase 2 in human chondrosarcoma
- (2012) Patricia F. Power et al. JOURNAL OF ORTHOPAEDIC RESEARCH
- Analysis of Gene Expression Regulated by the ETV5 Transcription Factor in OV90 Ovarian Cancer Cells Identifies FOXM1 Overexpression in Ovarian Cancer
- (2012) M. Llaurado et al. MOLECULAR CANCER RESEARCH
- Fibroblast growth factors and their receptors in cancer
- (2011) Jørgen Wesche et al. BIOCHEMICAL JOURNAL
- The A391E mutation enhances FGFR3 activation in the absence of ligand
- (2011) Fenghao Chen et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Taxol Resistance in Breast Cancer Cells Is Mediated by the Hippo Pathway Component TAZ and Its Downstream Transcriptional Targets Cyr61 and CTGF
- (2011) D. Lai et al. CANCER RESEARCH
- ETV5 transcription factor is overexpressed in ovarian cancer and regulates cell adhesion in ovarian cancer cells
- (2011) Marta Llauradó et al. INTERNATIONAL JOURNAL OF CANCER
- Overlapping functions of Pea3 ETS transcription factors in FGF signaling during zebrafish development
- (2010) Wade A. Znosko et al. DEVELOPMENTAL BIOLOGY
- The Hippo Tumor Pathway Promotes TAZ Degradation by Phosphorylating a Phosphodegron and Recruiting the SCFβ-TrCPE3 Ligase
- (2010) Chen-Ying Liu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- FGFs and metabolism
- (2009) Alexei Kharitonenkov CURRENT OPINION IN PHARMACOLOGY
- FGF-Regulated Etv Genes Are Essential for Repressing Shh Expression in Mouse Limb Buds
- (2009) Zhen Zhang et al. DEVELOPMENTAL CELL
- Fgf-Dependent Etv4/5 Activity Is Required for Posterior Restriction of Sonic hedgehog and Promoting Outgrowth of the Vertebrate Limb
- (2009) Junhao Mao et al. DEVELOPMENTAL CELL
- Molecular pathology of the fibroblast growth factor family
- (2009) Pavel Krejci et al. HUMAN MUTATION
- Antibody-based targeting of FGFR3 in bladder carcinoma and t(4;14)-positive multiple myeloma in mice
- (2009) Jing Qing et al. JOURNAL OF CLINICAL INVESTIGATION
- Mutant fibroblast growth factor receptor 3 induces intracellular signaling and cellular transformation in a cell type- and mutation-specific manner
- (2009) E di Martino et al. ONCOGENE
- V600EBRAF is associated with disabled feedback inhibition of RAF-MEK signaling and elevated transcriptional output of the pathway
- (2009) C. A. Pratilas et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Fibroblast growth factor regulation of neovascularization
- (2008) Masahiro Murakami et al. CURRENT OPINION IN HEMATOLOGY
- Reduced tumorigenesis in mouse mammary cancer cells following inhibition of Pea3- or Erm-dependent transcription
- (2008) V. Firlej et al. JOURNAL OF CELL SCIENCE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started